This inventor holds 2 USPTO granted patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Raphael Ceccaldi: Innovator in Cancer Treatment
Introduction
Raphael Ceccaldi is a prominent inventor based in Paris, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of new compounds and methods.
Latest Patents
Ceccaldi holds 2 patents related to compounds and methods for treating cancer. His latest patents focus on methods for treating homologous recombination (HR)-deficient cancers. The applications provide a method for treating cancer by administering to a subject a compound of Formula (I) or a pharmaceutically acceptable salt thereof.
Career Highlights
Ceccaldi is associated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research in oncology. His work is pivotal in developing new therapeutic strategies for cancer patients.
Collaborations
He collaborates with esteemed colleagues such as Alan D D'Andrea and Jia Zhou, contributing to a collective effort in cancer research and treatment.
Conclusion
Raphael Ceccaldi's innovative work in cancer treatment exemplifies the impact of dedicated research in the medical field. His contributions are vital for advancing therapeutic options for patients facing challenging cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile